These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8237091)

  • 21. TP53 and liver carcinogenesis.
    Staib F; Hussain SP; Hofseth LJ; Wang XW; Harris CC
    Hum Mutat; 2003 Mar; 21(3):201-16. PubMed ID: 12619106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation.
    Volkmann M; Hofmann WJ; Müller M; Räth U; Otto G; Zentgraf H; Galle PR
    Oncogene; 1994 Jan; 9(1):195-204. PubMed ID: 8302580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [p53 gene mutation in hepatocellular carcinoma].
    Jiang W; Lu Q; Pan G
    Zhonghua Wai Ke Za Zhi; 1998 Sep; 36(9):531-2. PubMed ID: 11825456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different levels of p53 induced either apoptosis or cell cycle arrest in a doxycycline-regulated hepatocellular carcinoma cell line in vitro.
    Lai PB; Chi TY; Chen GG
    Apoptosis; 2007 Feb; 12(2):387-93. PubMed ID: 17191126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 as a growth suppressor gene in HBV-related hepatocellular carcinoma cells.
    Puisieux A; Ponchel F; Ozturk M
    Oncogene; 1993 Feb; 8(2):487-90. PubMed ID: 8381223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program.
    Elliott K; Ge K; Du W; Prendergast GC
    Oncogene; 2000 Sep; 19(41):4669-84. PubMed ID: 11032017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Negative immunohistochemical staining of p53 protein does not always reflect wild-type p53 gene in cancer cells.
    Horiuchi H; Kawamata H; Omotehara F; Fujii S; Fujimori T; Kuroda Y
    J Gastroenterol; 2004 Aug; 39(8):801-3. PubMed ID: 15338377
    [No Abstract]   [Full Text] [Related]  

  • 28. Mutant p53 but not hepatitis B virus X protein is present in hepatitis B virus-related human hepatocellular carcinoma.
    Henkler F; Waseem N; Golding MH; Alison MR; Koshy R
    Cancer Res; 1995 Dec; 55(24):6084-91. PubMed ID: 8521397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GEP associates with wild-type p53 in hepatocellular carcinoma.
    Cheung ST; Wong SY; Lee YT; Fan ST
    Oncol Rep; 2006 Jun; 15(6):1507-11. PubMed ID: 16685387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Numerical aberrations of chromosome 17 and the p53 locus in small hepatocellular carcinomas.
    Yano H; Nanashima A; Hidaka S; Haseba M; Tanaka K; Yamaguchi H; Nakagoe T; Tagawa Y; Nagayasu T
    Anticancer Res; 2004; 24(1):111-5. PubMed ID: 15015584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 and p21/Waf1 protein expression and K-ras codon 12 mutation in carcinoma of the papilla of Vater.
    Zhao B; Kimura W; Futakawa N; Muto T; Kubota K; Harihara Y; Takayama T; Makuuchi M
    Am J Gastroenterol; 1999 Aug; 94(8):2128-34. PubMed ID: 10445539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of immunohistochemical staining and mutations of p53 in human hepatocellular carcinoma.
    Hsia CC; Nakashima Y; Thorgeirsson SS; Harris CC; Minemura M; Momosaki S; Wang NJ; Tabor E
    Oncol Rep; 2000; 7(2):353-6. PubMed ID: 10671685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of p53 in a large series of patients with hepatocellular carcinoma: a clinicopathological correlation.
    Caruso ML; Valentini AM
    Anticancer Res; 1999; 19(5B):3853-6. PubMed ID: 10628323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma.
    Yeh SH; Wu DC; Tsai CY; Kuo TJ; Yu WC; Chang YS; Chen CL; Chang CF; Chen DS; Chen PJ
    Clin Cancer Res; 2006 Feb; 12(4):1097-108. PubMed ID: 16489062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
    Xue KX
    Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tumor suppressor gene, p53, and hepatocarcinogenesis].
    Masutomi K; Kaneko S; Kobayashi K
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():138-41. PubMed ID: 11761930
    [No Abstract]   [Full Text] [Related]  

  • 37. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
    Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 genetic abnormalities and P-glycoprotein expression in stump and primary gastric carcinomas.
    Oliver I; Lacueva J; Barberá V; Caldés T; Teruel A; Costa D; Medrano J; Pérez-Vázquez T; Quesada P; Ferragut J; Calpena R
    Hepatogastroenterology; 2007 Mar; 54(74):377-81. PubMed ID: 17523278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
    J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of Aflatoxin-Associated
    Jiao J; Niu W; Wang Y; Baggerly K; Ye Y; Wu X; Davenport D; Almeda JL; Betancourt-Garcia MM; Forse RA; Stevenson HL; Watt GP; McCormick JB; Fisher-Hoch SP; Beretta L
    Cancer Prev Res (Phila); 2018 Feb; 11(2):103-112. PubMed ID: 29089331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.